Published in Br J Dermatol on September 01, 1982
Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest (1966) 8.64
DNA:anti-DNA complexes: their detection in systemic lupus erythematosus sera. J Clin Invest (1973) 2.66
Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol (1983) 2.59
Antibodies to polynucleotides: distribution in human serums. Science (1969) 2.43
Fibronectin fragment(s) are chemotactic for human peripheral blood monocytes. J Immunol (1982) 2.29
Variable patterns of immunoglobulin and complement deposition in the kidneys of patients with systemic lupus erythematosus. Am J Pathol (1969) 2.11
Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes. J Clin Invest (1984) 2.10
Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. J Invest Dermatol (1990) 2.03
Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment. J Biol Chem (1988) 1.97
Studies on DNA antibodies using DNA labelled with actinomycin-D (3H) or dimethyl (3H) sulphate. Clin Exp Immunol (1969) 1.88
Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest (1993) 1.87
Epidemic viral hepatitis, type B, in hospital personnel. Am J Med (1974) 1.87
Intravenous iron dextran in clinical medicine. JAMA (1980) 1.52
Isolation of functional subsets of human peripheral blood monocytes. J Immunol (1979) 1.52
Ras mutations in human melanoma: a marker of malignant progression. J Invest Dermatol (1994) 1.50
Detection of herpes simplex virus DNA in cutaneous lesions of erythema multiforme. J Invest Dermatol (1989) 1.50
Varicella-zoster virus infection of human mononuclear cells. Virus Res (1987) 1.46
Gastrointestinal involvement in leukocytoclastic vasculitis and polyarteritis nodosa. J Rheumatol (1981) 1.42
Chronic membranous glomerulonephritis caused by hepatitis B antigen-antibody immune complexes. Ann Intern Med (1974) 1.34
The prognostic and therapeutic implications of DNA:anti-DNA immune complexes in systemic lupus erythematosus (SLE). Am J Med (1975) 1.30
Mosses as biomonitors of atmospheric heavy metal deposition: spatial patterns and temporal trends in Europe. Environ Pollut (2010) 1.29
Exercise-induced anaphylactic reaction to shellfish. J Allergy Clin Immunol (1979) 1.28
Wheat protein antibodies in dermatitis herpetiformis. J Invest Dermatol (1979) 1.26
Influence of inflammatory mediators and cytokines on human melanocyte function. J Invest Dermatol (1993) 1.25
Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-alpha from human keratinocytes. J Invest Dermatol (1996) 1.23
A serological marker for neonatal lupus erythematosus. Br J Dermatol (1982) 1.20
Acquired immunodeficiency syndrome in a patient with hemophilia. Ann Intern Med (1983) 1.19
Immune complex vasculitis as a cause of ascites and pleural effusions in systemic lupus erythematosus. J Rheumatol (1978) 1.17
A potential role for superantigens in the pathogenesis of psoriasis. J Invest Dermatol (1993) 1.17
Identification of functional platelet-activating factor receptors on human keratinocytes. J Invest Dermatol (1995) 1.15
Interleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol (1992) 1.12
Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med (1985) 1.11
Mycoplasma pneumoniae infection is associated with Stevens-Johnson syndrome, not erythema multiforme (von Hebra). J Am Acad Dermatol (1996) 1.11
Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest (1995) 1.10
Lupus meningitis. Antibody to deoxyribonucleic acid (DNA) and DNA:anti-DNA complexes in cerebrospinal fluid. Ann Intern Med (1974) 1.10
Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol (1995) 1.08
Anaphylaxis. A preventable emergency. Postgrad Med (1990) 1.08
Evidence of an autologous immune complex pathogenic mechanism in acute poststreptococcal glomerulonephritis. Kidney Int (1978) 1.07
Anaphylaxis after intravenous methylprednisolone administration. JAMA (1981) 1.05
The effects of H1 and H2 antihistamines on histamine inhalation challenges in asthmatic patients. Am Rev Respir Dis (1979) 1.05
Anti-DNA activity of IgG F(ab')2 from normal human serum. J Immunol (1979) 1.04
Modulation of melanocyte intercellular adhesion molecule-1 by immune cytokines. J Invest Dermatol (1990) 1.03
Lymphocytotoxic antibodies in multiple sclerosis. Clin Immunol Immunopathol (1977) 1.02
A controlled trial of therapy in chronic urticaria. J Allergy Clin Immunol (1981) 1.02
Trends in wound repair: cellular and molecular basis of regenerative therapy using electromagnetic fields. Curr Mol Med (2012) 1.02
Zinc correction of defective chemotaxis in acrodermatitis enteropathica. Arch Dermatol (1977) 1.01
Mixed cryoglobulinemia, 125I C1q binding and skin immunofluorescence in erythema multiforme. J Invest Dermatol (1980) 1.01
Melanocyte mitogens induce both melanocyte chemokinesis and chemotaxis. J Invest Dermatol (1995) 1.01
Delayed pressure urticaria. J Allergy Clin Immunol (1982) 1.00
Immune complexes and antibodies to BCG in sera from patients with mycobacterial infections. Clin Exp Immunol (1980) 1.00
Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Pharm Res (1998) 0.99
Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice. J Clin Invest (1989) 0.99
A study of serum antibodies to isolated milk proteins and ovalbumin in infants and children. Clin Allergy (1977) 0.98
Cultured human keratinocytes synthesize and secrete endothelin-1. J Invest Dermatol (1993) 0.97
Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity. Clin Exp Immunol (1999) 0.97
Expression of E and P-cadherin by melanoma cells decreases in progressive melanomas and following ultraviolet radiation. J Invest Dermatol (1996) 0.96
Antibodies to bovine gamma globulin (BGG) and the occurrence of a BGG-like substance in systemic lupus erythematosus sera. J Allergy Clin Immunol (1972) 0.96
Enhancement of specific immunofluorescent findings with use of a para-phenylenediamine mounting buffer. J Invest Dermatol (1982) 0.96
The keratinocyte as a target for staphylococcal bacterial toxins. J Investig Dermatol Symp Proc (2001) 0.96
Anti-DNA antibodies and renal lesions of patients with systemic lupus erythematosus. Transplant Proc (1969) 0.96
Human herpesvirus 6 is present in lesions of Langerhans cell histiocytosis. J Invest Dermatol (1993) 0.96
The effect of immunosuppressive and anti-inflammatory drugs on monocyte function in vitro. J Lab Clin Med (1977) 0.96
Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis: a potential role in the modulation of IgE synthesis. J Immunol (1998) 0.95
Hepatitis A and facilities for preschool children. J Infect Dis (1975) 0.95
The histopathologic evolution of recurrent herpes simplex labialis. J Am Acad Dermatol (1981) 0.95
Vasculitis in chronic urticaria. J Allergy Clin Immunol (1980) 0.95
Lymphocytotoxic antibodies in family members of patients with multiple sclerosis. Lancet (1978) 0.95
Chronic graft-versus-host disease as a model for scleroderma. II. Mast cell depletion with deposition of immunoglobulins in the skin and fibrosis. Cell Immunol (1985) 0.95
Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. Another possible mechanism for estradiol influence of lupus erythematosus. J Immunol (1988) 0.94
The effect of H1 and H2 blockade on cutaneous histamine response in man. J Allergy Clin Immunol (1980) 0.94
DOPA-negative melanocytes in the outer root sheath of human hair follicles express premelanosomal antigens but not a melanosomal antigen or the melanosome-associated glycoproteins tyrosinase, TRP-1, and TRP-2. J Invest Dermatol (1996) 0.93
Increased proliferative response of human peripheral blood lymphocytes to anti-immunoglobulin antibodies in elderly people. Clin Immunol Immunopathol (1978) 0.93
Detection of a herpes simplex viral antigen in skin lesions of erythema multiforme. Ann Intern Med (1984) 0.93
Erythema multiforme: clinical, histopathologic, and immunologic study. J Am Acad Dermatol (1984) 0.93
Leukotrienes C4 and D4 as potent mitogens for cultured human neonatal melanocytes. J Invest Dermatol (1989) 0.92
Pyoderma gangrenosum. Abnormal monocyte function corrected in vitro with hydrocortisone. Arch Dermatol (1978) 0.92
Comparison of DNA binding in normal population, general hospital laboratory personnel, and personnel from laboratories studying SLE. J Rheumatol (1975) 0.92
An animal model of antibody binding in cutaneous lupus. Arthritis Rheum (1986) 0.92
Expression of fibronectin, laminin, and factor VIII-related antigen during development of the human cutaneous microvasculature. J Invest Dermatol (1985) 0.92
Antibody-dependent cellular cytotoxicity and skin disease. J Invest Dermatol (1985) 0.92
The role of RNP, Sm, and SS-A/Ro-specific antisera from patients with lupus erythematosus in inducing antibody-dependent cellular cytotoxicity (ADCC) of targets coated with nonhistone nuclear antigens. Clin Immunol Immunopathol (1984) 0.91
Childhood pemphigus foliaceus: case report and review of the literature. Pediatr Dermatol (1986) 0.91
Oral exposure to alloantigen generates intragraft CD8+ regulatory cells. J Immunol (2001) 0.91
Evaluation of a patient with both aquagenic and cholinergic urticaria. J Allergy Clin Immunol (1981) 0.91
Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis. J Clin Invest (1999) 0.91
Lymphocytotoxic antibodies in systemic lupus erythematosus and clinically related diseases. Arthritis Rheum (1979) 0.90
Immunogenetics of the neonatal lupus syndrome. Ann Intern Med (1983) 0.90
Overexpression of mutant ras in human melanoma increases invasiveness, proliferation and anchorage-independent growth in vitro and induces tumour formation and cachexia in vivo. Melanoma Res (1999) 0.89
Reversible resistance to apoptosis in cutaneous T cell lymphoma. Ann N Y Acad Sci (2001) 0.89
The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases. Br J Dermatol (1998) 0.89
Initial lesion size as a predictive factor in determining the response of port-wine stains in children treated with the pulsed dye laser. Arch Pediatr Adolesc Med (1995) 0.89
Anti-native DNA antibodies in discoid lupus erythematosus. Arch Dermatol (1972) 0.89
Oligoclonal expansion of intraepidermal T cells in psoriasis skin lesions. J Invest Dermatol (2001) 0.89